Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Literature
1.
Schuster A, Duckett SG, Hedström E, Chiribiri A, Techen G, Nagel E (2011) Noncompaction of the myocardium: the value of cardiovascular magnetic resonance imaging. J Am Coll Cardiol 58:e25PubMedCrossRef
2.
Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J, Nagel E, Lombardi M, van Rossum AC, Wagner A, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahrholdt H (2009) Eurocmr (european cardiovascular magnetic resonance) registry: results of the german pilot phase. J Am Coll Cardiol 54:1457–1466PubMedCrossRef
Metadata
Title
Value of cardiovascular magnetic resonance imaging in myocardial hypertrophy
Authors
Andreas Schuster
Masaki Ishida
Geraint Morton
Boris Bigalke
Mufaddal T. Moonim
Eike Nagel
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Clinical Research in Cardiology / Issue 3/2012
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-011-0401-5

Other articles of this Issue 3/2012

Clinical Research in Cardiology 3/2012 Go to the issue

Original Paper

Time-dependency, predictors and clinical impact of infarct transmurality assessed by magnetic resonance imaging in patients with ST-elevation myocardial infarction reperfused by primary coronary percutaneous intervention

Original Paper

Early remodeling processes as predictors of diastolic function 5 years after reperfused acute myocardial infarction and intracoronary progenitor cell application

Original Paper

Smoking restrictions and hospitalization for acute coronary events in Germany

Original Paper

First clinical evaluation of a novel capacitive ECG system in patients with acute myocardial infarction

Original Paper

Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation

Original Paper

Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits